Can you name the protein in lipitor's pathway?

Can Lipitor block the HMG-CoA reductase enzyme?
Lipitor (atorvastatin) directly inhibits the HMG-CoA reductase protein that catalyzes the conversion of HMG-CoA to mevalonate, the committed step in cholesterol synthesis.

What protein does Lipitor bind to inside cells?
The drug binds the catalytic domain of HMG-CoA reductase on the endoplasmic reticulum, locking the enzyme in an inactive conformation.

How does blocking that protein lower LDL cholesterol?
Reduced mevalonate production lowers downstream isoprenoids and cholesterol, prompting liver cells to up-regulate LDL receptors that clear circulating LDL from blood.

Is HMG-CoA reductase the only protein Lipitor affects?
At standard doses the primary target is HMG-CoA reductase; off-target interactions with other proteins are minimal and not clinically significant.

When does the patent on atorvastatin expire?
The key U.S. composition-of-matter patent for atorvastatin expired in 2011, opening the market to generic versions.

Who makes generic atorvastatin today?
Multiple manufacturers, including Teva, Mylan, and Ranbaxy, produce generic atorvastatin under Abbreviated New Drug Applications approved by the FDA.

What side effects are patients asking about?
Muscle pain, elevated liver enzymes, and new-onset diabetes are the most commonly reported adverse effects linked to HMG-CoA reductase inhibition.

Can other statins be substituted if atorvastatin causes problems?
Pravastatin, rosuvastatin, and simvastatin also inhibit HMG-CoA reductase but differ in potency, metabolism, and drug-interaction profiles, allowing clinicians to switch agents when needed.

DrugPatentWatch.com